Single nucleotide polymorphisms (SNPs) within binding sites of microRNAs (miRNAs) --
site SNP rs6504593 in the IGF2BP1 3ʹ-UTR may alter IGF2BP1 expression and contribute to colorectal cancer risk.
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| INTRODUCTION
Colorectal cancer is one of the main causes of cancer-related mortality in the United States. They are projected to be 140 250 new colorectal cancer cases and 50 630 deaths in 2018. 1 In China, colorectal cancer is also a public health concern due to the rapid increase in morbidity in recent decades. 2 Colorectal cancer is known as a complex disease because of environmental and genetic factors and their interactions. Despite enormous efforts that have been devoted to exploring the pathogenesis of colorectal cancer, the precise etiology remains to be elucidated.
MicroRNAs (miRNAs) are endogenous, small non-coding RNAs (18-23 nucleotides) that silence gene expression by binding to target mRNA 3ʹ-untranslated regions (3ʹ-UTRs). 3 Previously, a few studies have reported that single nucleotide polymorphisms (SNPs) in miRNA target sites can influence miRNA-mediated gene regulation and play an important role in tumorigenesis. [4] [5] [6] MicroRNA-21 (miR-21) was upregulated in various tumors including gastric cancer, colorectal cancer, malignant breast tumor and pancreatic carcinoma. [7] [8] [9] [10] [11] Moreover, miR-21 affected the processes involved in the progression of colorectal cancer by directly targeting genes including RHOB, PDCD4 and Cdc25A. [12] [13] [14] [15] [16] Our previous study found that miR-21 could be a valuable biomarker for the diagnosis of colorectal cancer, 17 but the relationship between SNPs within its binding sites and colorectal cancer risk has not been investigated. Therefore, we aimed to investigate whether genetic variants within the binding sites of miR-21 could alter the susceptibility of patients for colorectal cancer.
| MATERIALS AND METHODS

| Study population
We conducted a case-control study including 1147 colorectal cancer individuals and 1203 cancer-free controls. In brief, the participants were consecutively recruited from The First Affiliated Hospital and Nanjing First Hospital of Nanjing Medical University beginning in September 2010 and were histopathologically confirmed. The cancer-free controls were randomly selected from individuals who participated in physical examinations and were frequency-matched by age (±5 years) and sex. This study protocol was approved by the Institutional Review Board of Nanjing Medical University. Previous studies have described the detailed information of the study subjects.
18,19
| SNPs selection
We focused on both the miR-21 target genes dataset and 3ʹ-UTR dataset using the UCSC browser (http://www.genome.ucsc.edu).
Using the algorithm TargetScan 
| SNPs genotyping
Assay System (Promega) was used to measure the luciferase activity, and the Renilla luciferase activity was normalized to Firefly luciferase activity.
| Quantitative reverse transcription polymerase chain reaction
Colorectal tumor tissues and their paired adjacent normal tissues were collected from colorectal cancer subjects. The clinical characteristics are provided in 
| Statistical analysis
| RESULTS
| Demographic and clinical characteristics of subjects
The demographic and clinical characteristics of cases and controls are presented in Table S3 . No significant differences were detected between colorectal cancer individuals and cancer-free controls for age (P = 0.751), gender (P = 0.116), smoking status (P = 0.097) and alcohol drinking status (P = 0.113). However, a higher proportion of family history of cancers was observed in colorectal cancer cases than in controls (P < 0.001). Of all colorectal cancer cases, the fre- 
| Association between selected SNPs and colorectal cancer susceptibility
The baseline characteristics of the selected SNPs are summarized in 
| Stratification analysis of rs6504593 and rs1049109
We further conducted stratification analysis by demographic characteristics to assess the associations of rs6504593 and rs1049109
with colorectal cancer risk under a dominant model. For rs6504593, subjects carrying the TC/CC genotype had an enhanced susceptibility of colorectal cancer in subgroups of non-smokers (P = 0.010), non-drinkers (P = 0.013) and individuals with a family history of cancers (P = 0.003), compared with the TT genotype (Table S5 ). For rs1049109, we identified a significantly increased risk in subgroups of older individuals (P = 0.001), females (P = 0.011), non-smokers (P = 0.012), non-drinkers (P = 0.002) and individuals both with family history of cancers (P = 0.026) and without family history of cancers (P = 0.037) for carriers of the CT/TT genotype comparing with the CC genotype (Table S6) . (Table S7) .
| miR-21 and its target genes' expression in colorectal cancer tissues
We measured the expression of miR-21 in colorectal tumor and adjacent normal tissues and found that miR-21 expression was significantly upregulated in tumor tissues compared to normal tissues (P < 0.001) ( Figure 1A ). This result was consistent with the data obtained from TCGA (P < 0.001) ( Figure 1B ). IGF2BP1 expression showed no significant difference between colorectal cancer and adjacent normal tissues (P = 0.177) ( Figure 1C ), whereas TCGA data showed that IGF2BP1 expression in colorectal cancer tissues was significantly higher than that in normal tissues (P < 0.001) ( Figure 1D ).
The expression level of ALPP in colorectal cancer and adjacent normal tissues was almost undetectable, which was supported by data in TCGA. Therefore, IGF2BP1 was retained for further analysis.
Moreover, a negative association between IGF2BP1 and miR-21 expression was discovered in both colorectal tumor tissues (r = −0.348, P = 0.029) and normal tissues (r = −0.401, P = 0.010), although no significant correlation was found by using TCGA data ( Figure S1 ).
| SNP rs6504593 interfere miR-21 and IGF2BP1
3ʹ-UTR interaction
To demonstrate whether rs6504593 regulates IGF2BP1 expression by miR-21, we performed dual-luciferase reporter assays by constructing psiCHECK-2 vectors containing wild-type or mutated-type IGF2BP1 3ʹ-UTR (Figure 2A ). The specific binding sites of IGF2BP1
3ʹ-UTR and miR-21 were provided by bioinformatics tools (Figure 2B) . The results indicated that constructs containing the rs6504593 T allele significantly reduced luciferase activity compared with the C allele in HCT116 and SW620 cells (P = 0.003 and P = 0.012, respectively) ( Figure 2C ). These data suggested that miR-21 may directly target the IGF2BP1 3ʹ-UTR with the rs6504593 T allele. 
T A B L E 1 Association of selected SNPs with the risk of colorectal cancer in four genetic models
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| eQTL analysis of IGF2BP1
To understand whether rs6504593 can regulate the expression of IGF2BP1, we performed an eQTL analysis in TCGA data. We found that rs6504593 genotypes had no influence on IGF2BP1 expression in either colorectal cancer tissues or normal tissues (P = 0.705 and P = 0.774, respectively) ( Figure S2 ).
| Functional characteristics of miR-21 in colorectal cancer cells
The functional mechanism of miR-21 was characterized after transiently transfecting miR-21 mimics or inhibitor into SW620 and HCT116 cells. SW620 cells transfected with miR-21 mimics significantly increased cell proliferation (P = 0.004) and suppressed cell apoptosis (P = 0.009) ( Figure 3A,B) . SW620 cells transfected with miR-21 inhibitor significantly decreased cell proliferation (P = 0.047) and showed increased cell apoptosis (P < 0.001) ( Figure 3A,B) . Next, HCT116 cells transfected with miR-21 mimics significantly increased cell proliferation (P = 0.012) but did not significantly induce cell apoptosis changes ( Figure S3A,B) . HCT116 cells transfected with miR-21 inhibitor significantly decreased cell proliferation (P < 0.001) and increased cell apoptosis (P = 0.046) ( Figure S3A,B) . In addition, HCT116 and SW620 cells transfected with miR-21 mimics did not profoundly alter the cell cycle ( Figure S4A,B) .
| DISCUSSION
In this study, we investigated the association between genetic variants in miR-21 binding sites and colorectal cancer susceptibility in a case-control study. Our finding shows that rs1049109 and rs6504593 were new susceptibility SNPs for colorectal cancer, which have not been reported in previous studies.
IGF2BP1, belonging to the family of RNA-binding proteins, plays key roles in many biological processes through binding to the key motif in RNA structures. 20 The abnormal expression of IGF2BP1 may cause a series of diseases, including malignant tumors. 21, 22 Recent research has reported that IGF2BP1 expression levels were upregulated in many types of tumors, such as hepatocellular carcinoma, renal cell carcinoma and cutaneous squamous cell carcinoma. [23] [24] [25] In our study, the expression of IGF2BP1 in colorectal cancer tissues, including TCGA data, was almost concordant with previous studies. [23] [24] [25] However, no significant difference was detected in our 
